{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:35:57Z","timestamp":1777581357930,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1016\/j.ygyno.2005.02.010","type":"journal-article","created":{"date-parts":[[2005,3,18]],"date-time":"2005-03-18T14:42:40Z","timestamp":1111156960000},"page":"483-488","source":"Crossref","is-referenced-by-count":23,"title":["Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial cancer, endometrial hyperplasia, and normal endometrium"],"prefix":"10.1016","volume":"97","author":[{"given":"Francisco J.","family":"Orejuela","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lois M.","family":"Ramondetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jubilee","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciano B.","family":"Lemos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa M.","family":"Hollier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2005.02.010_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/canjclin.46.1.5","article-title":"Cancer statistics, 1996","volume":"46","author":"Parker","year":"1996","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2005.02.010_bib2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","article-title":"Two pathogenetic types of endometrial carcinoma","volume":"15","author":"Borkhman","year":"1983","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.02.010_bib3","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJM199608293350907","article-title":"Endometrial carcinoma","volume":"335","author":"Rose","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2005.02.010_bib4","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1207\/S15327914NC4502_05","article-title":"Serum fatty acids and breast cancer incidence","volume":"45","author":"Rissanen","year":"2003","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.ygyno.2005.02.010_bib5","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1093\/carcin\/20.12.2209","article-title":"Dietary polyunsaturated fatty acids and cancers of the breast and colorectum: emerging evidence for their role as risk modifiers","volume":"20","author":"Bartsch","year":"1999","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ygyno.2005.02.010_bib6","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/BF02535853","article-title":"Dietary fat, fatty acids, and prostate cancer","volume":"27","author":"Rose","year":"1992","journal-title":"Lipids"},{"key":"10.1016\/j.ygyno.2005.02.010_bib7","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/(SICI)1097-0215(19980812)77:4<511::AID-IJC6>3.0.CO;2-X","article-title":"Non-steroidal anti-inflammatory drugs and prostate cancer progression","volume":"77","author":"Norrish","year":"1998","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2005.02.010_bib8","first-page":"306","article-title":"An introduction to aspirin, NSAIDS, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part II","volume":"19","author":"Moyad","year":"2001","journal-title":"Semin. Urol. Oncol."},{"key":"10.1016\/j.ygyno.2005.02.010_bib9","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1046\/j.1365-2036.2000.014s1064.x","article-title":"Review article: cyclooxygenase a target for colon cancer prevention","volume":"14","author":"Dubois","year":"2000","journal-title":"Aliment Pharmacol. Ther."},{"key":"10.1016\/j.ygyno.2005.02.010_bib10","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1006\/gyno.1999.5690","article-title":"High cyclooxygenase-2 expression in stage IB cervical cancer with lymph node metastases of parametrial invasion","volume":"76","author":"Ryu","year":"2000","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.02.010_bib11","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/jnci\/90.6.455","article-title":"Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer","author":"Hwang","year":"1998","journal-title":"J. Natl. Cancer Res."},{"key":"10.1016\/j.ygyno.2005.02.010_bib12","first-page":"2651","article-title":"Correlation between cyclo-oxygenase-2 expression and angiogenesis in human breast cancer","volume":"9","author":"Giles","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2005.02.010_bib13","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/1097-0142(20000801)89:3<589::AID-CNCR14>3.0.CO;2-C","article-title":"Expression of cyclooxygenase-2 in prostate carcinoma","volume":"89","author":"Yoshimura","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2005.02.010_bib14","first-page":"519","article-title":"Increased expression of cyclooxygenase-2 protein in human gastric carcinoma","volume":"6","author":"Lim","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2005.02.010_bib15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0002-9440(10)64513-0","article-title":"Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas","volume":"157","author":"Komhoff","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ygyno.2005.02.010_bib16","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1046\/j.1471-4159.2001.00264.x","article-title":"Up-regulation of cyclo-oxygenase-1 in neuroblastoma cell lines by retinoic acid and corticosteroids","volume":"77","author":"Schneider","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ygyno.2005.02.010_bib17","first-page":"1146","article-title":"Regulation of cycloxygenase-2 expression in bovine chondrocytes in culture by interleukin 1 alpha, tumor necrosis factor alpha, glucocorticoids, and 17 beta estradiol","volume":"25","author":"Morisset","year":"1998","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.ygyno.2005.02.010_bib18","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1210\/jc.84.9.3364","article-title":"Treatment of human endometrial gland epithelial cells with chronic gonadotropin\/luteinizing hormone increases the expression of the cyclooxygenase-2 gene","volume":"84","author":"Zhou","year":"1999","journal-title":"J. Clin. Endocrin. Metab."},{"key":"10.1016\/j.ygyno.2005.02.010_bib19","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S1470-2045(01)00488-0","article-title":"Cyclooxygenase 2: a pharmacological target for the prevention of cancer","volume":"2","author":"Dannenberg","year":"2001","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2005.02.010_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1158\/1541-7786.632.2.11","article-title":"Cox-2 induces apoptosis in breast cancer cells in an in vivo model of spontaneous metastatic breast cancer","volume":"2","author":"Basu","year":"2004","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.ygyno.2005.02.010_bib21","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/molehr\/5.10.961","article-title":"Expression of cyclooxygenase in human endometrium during the implantation period","volume":"5","author":"Marions","year":"1999","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.ygyno.2005.02.010_bib22","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/sj.neo.7900119","article-title":"Heightened expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor in human endometrial adenocarcinoma","volume":"2","author":"Tong","year":"2000","journal-title":"Neoplasia"},{"key":"10.1016\/j.ygyno.2005.02.010_bib23","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1053\/hupa.2002.31292","article-title":"Cyclooxygenase-2 expression in endometrial cancer: correlation with microvessel count and expression of vascular endothelial growth factor and thymidine phosphorylase","volume":"33","author":"Fujiwaki","year":"2002","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.ygyno.2005.02.010_bib24","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/cncr.10736","article-title":"Cyclooxygenase-2 expression in endometrial carcinoma. Correlation with clinicopathologic parameters and clinical outcome","volume":"95","author":"Ferrandina","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2005.02.010_bib25","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1067\/mob.2003.284","article-title":"Expression of cyclooxygenase-2 in cervical, endometrial, and ovarian malignancies","volume":"188","author":"Landen","year":"2003","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2005.02.010_bib26","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/00004347-200204000-00007","article-title":"Expression of COX-2, Ki67, cyclin D1, and P21 in endometrioid carcinomas","volume":"21","author":"Cao","year":"2002","journal-title":"Intl. J. Gynecol. Pathol."},{"key":"10.1016\/j.ygyno.2005.02.010_bib27","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jsbmb.2003.07.004","article-title":"Cyclooxygenase-2 and chemoprevention of breast cancer","volume":"86","author":"Davies","year":"2003","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.ygyno.2005.02.010_bib28","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0960-0760(03)00378-9","article-title":"Breast cancer prevention\u2014clinical trials strategies involving aromatase inhibitors","volume":"86","author":"Goss","year":"2003","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.ygyno.2005.02.010_bib29","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1001\/jama.291.20.2433","article-title":"Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk","volume":"291","author":"Terry","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2005.02.010_bib30","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.1210\/en.137.12.5739","article-title":"Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene","volume":"137","author":"Zhao","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.ygyno.2005.02.010_bib31","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1677\/joe.0.1800135","article-title":"Expression of enzyme associated with steroid hormone synthesis and local production of steroid hormone in endometrial carcinoma cells","volume":"180","author":"Sugawara","year":"2004","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ygyno.2005.02.010_bib32","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/jnci\/94.4.252","article-title":"Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues","volume":"94","author":"Thun","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2005.02.010_bib33","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJM199112053252301","article-title":"Aspirin use and reduced risk of fatal colon cancer","volume":"325","author":"Thun","year":"1991","journal-title":"N. Engl. J. Med."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825805001228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825805001228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T03:29:32Z","timestamp":1706066972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825805001228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S0090825805001228"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2005.02.010","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}